A new SELEX scheme is proposed for the selection of aptamers targeting a specific epitope of a native protein. Anti-sialic acid receptor (SAR) aptamers that inhibit H1 hemagglutination at a low picomole dose are selected accordingly.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c4cc03116d | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!